What makes Brazil’s largest professional cannabis expo essential for cultivation and extraction technology providers in Latin America’s fastest-growing market?
Cannabis Fair Sao Paulo 2026 marks a pivotal moment for Brazil’s cannabis industry. Now in its 5th edition and rebranded from “Medical Cannabis Fair,” this professional B2B event reflects the maturation of Latin America’s largest cannabis market from a purely medical focus to a comprehensive value chain approach spanning cultivation, extraction, distribution, and finished products.
The rebranding signals Brazil’s industry evolution, with this edition encompassing the full cannabis value chain across seven exhibition sectors: Cultivation, Extraction, Services, Distribution, Products, and Packaging. The expanded scope reflects market participants preparing for comprehensive domestic production.
“
672,000 patients are served by Brazil’s medical cannabis market, with 56% annual patient growth driving market expansion.
Whether you’re seeking ANVISA-compliant product partnerships, evaluating cultivation equipment for anticipated domestic production, or exploring distribution channels across Latin America’s largest economy, Cannabis Fair Sao Paulo brings together the decision-makers shaping the future of Brazilian cannabis operations.
Cannabis Fair Sao Paulo 2026 at a Glance 🇧🇷
Dates
May 21-23, 2026
Location
Transamerica Expo Center, Sao Paulo, Brazil
Expected Attendance
4,600+ B2B professionals
Exhibitors
80+ companies
Edition
5th Edition (Rebranded)
Official Website
cannabisfair.com.br
Confirmed
Last verified: January 3, 2026
Sao Paulo
23.55°S 46.63°W
Who Should Attend Cannabis Fair Sao Paulo
Cannabis Fair Sao Paulo attracts a specialized B2B audience focused on serving Brazil’s rapidly expanding medical cannabis market. The event’s seven exhibition sectors create opportunities for specific industry segments.
Cultivation equipment suppliers preparing for domestic production
Extraction technology vendors targeting pharmaceutical manufacturers
Pharmaceutical companies with ANVISA-compliant products
Compliance and regulatory consultants serving ANVISA requirements
Distribution and logistics professionals specializing in imports
International importers and exporters seeking Brazilian partnerships
Why Cannabis Fair Sao Paulo Matters in 2026
PL 399/2015 Cultivation Bill Decision Year: Brazilian legislators and researchers have identified 2026 as the “decisive year” for domestic cultivation authorization. The bill, which passed a special committee in 2021, awaits plenary discussion. ANVISA Director Thiago Campos faces a March 2026 STJ deadline for cultivation regulation.
Sechat Talks Launch: This edition introduces Sechat Talks, featuring expert presentations with live streaming. This content track creates additional opportunities for thought leadership and industry education.
5th Edition Milestone: The event’s longevity demonstrates sustained industry commitment despite regulatory complexity, signaling market stability for international participants.
Brazil ranks as the largest medical cannabis market in Latin America with 24.6% projected CAGR through 2030, serving 672,000+ patients through import-dependent channels.
Kaya Mind Yearbook 2024 & Cognitive Market ResearchPlanning Your Cannabis Fair Sao Paulo Trip
Whether you’re attending for the first time or returning to expand your network, these practical tips will help you maximize your conference experience.
Hotels and Accommodation
- Santo Amaro area: Closest to venue, convenient for early arrivals and evening networking
- Brooklin/Itaim Bibi: Business districts with international hotel brands, 15-20 minutes from venue
- Faria Lima corridor: Major business area with extensive hospitality options
- Book accommodations early as Sao Paulo hosts numerous concurrent business events
Schedule Overview
- Day 1: Exhibitor meetings and Sechat Talks sessions
- Day 2: In-depth partnership discussions and demonstration appointments
- Day 3: Follow-up conversations and closing negotiations
- Three-day format provides adequate time for comprehensive networking
Transit and Arrival
- Guarulhos International Airport (GRU): 45-60 minutes from venue, most international flights
- Congonhas Airport (CGH): 20-30 minutes from venue, domestic and regional connections
- Allow substantial buffer time for ground transportation during rush hours
- Venue: Transamerica Expo Center, Santo Amaro district, south zone
Exhibitor Tips
- Portuguese Language: Bring Portuguese-speaking team members or arrange interpretation
- ANVISA Documentation: Prepare translated company credentials and GMP certifications
- Cultural Note: Brazilian business culture values relationship building – allow time for conversations
- Product docs should include Portuguese translations for regulatory discussions
Brazil Cannabis Regulatory Context
Key Regulatory Topics at Cannabis Fair Sao Paulo
- RDC 327/2019 (Companies): Requires Brazilian pharmaceutical company partnership, foreign entities cannot register products directly, GMP certification mandatory
- RDC 660/2022 (Patients): Individual patient imports requiring valid Brazilian physician prescription and ANVISA registration
- THC Limits: Products must contain predominantly CBD with no more than 0.2% THC (exceptions for terminal patients)
- Prescription Requirements: Type B (blue form) for standard products; Type A (yellow form) for higher-THC products
Brazil’s medical cannabis market operates under a complex regulatory framework. All products currently enter through import channels regulated by ANVISA (Agencia Nacional de Vigilancia Sanitaria). GMP certification (CBPF, WHO GMP, or PIC/S) is mandatory, with 5-year sanitary authorization under review for extension.
Related: Cannabis Cultivation Software🇧🇷 Brazil’s Cannabis Framework: Import-Dependent to Domestic Cultivation?
Brazil presents a unique market model that international cannabis companies must understand. As Latin America’s largest medical cannabis market, all products currently enter through import channels with zero domestic cultivation permitted.
Key Facts for Cannabis Fair Attendees
- 1. Zero Domestic Cultivation: All cannabis products are imported as extracts or semi-processed substrates. No plant material or flower imports permitted.
- 2. 500+ Exporting Companies: International suppliers from the USA, Canada, Colombia, Uruguay, Netherlands, and Spain serve the Brazilian market through 600+ products.
- 3. $349 Million Market (2025): Brazil ranks among top 10 global medical cannabis markets by USD value and leads Latin America.
- 4. 56% Annual Patient Growth: The patient base expanded from 430,000 (2023) to 672,000 (2024), with projections exceeding R$1 billion market value in 2025.
- 5. Embrapa Research Program: Brazil’s agricultural research agency launched a 12-year hemp cultivation research initiative in February 2025, preparing scientific foundation for domestic production.
- 6. Three Legal Channels: RDC 660 Imports (47%), RDC 327 Pharmacy Products (31%), and Patient Associations (22%) serve the 672,000 patient base.
Did You Know?
672,000 Brazilian patients access medical cannabis through one of three legal channels, yet high costs from import dependency limit access for lower-income patients. Domestic cultivation could reduce costs 60-80% and expand market accessibility dramatically.
What This Means for Attendees
Cannabis Fair Sao Paulo 2026 occurs at a critical juncture. If cultivation legislation advances, first-mover cultivation technology providers will capture significant market share. If import-dependency continues, existing supply chain relationships become even more valuable.
Note: Laws and enforcement can change. This information is for educational purposes only.
Operational Challenges Facing Brazilian Cannabis Operators
Cannabis businesses expanding into the Brazilian market encounter operational complexities that require significant planning and system adaptation. Conference attendees frequently discuss these common challenges:
-
ANVISA Authorization Complexity
Navigating the complex authorization requirements of RDC 327/660 compliance, including mandatory Brazilian pharmaceutical company partnerships for product registration
-
Import Dependency Supply Chain
Managing specialized cold-chain logistics and customs expertise for a 100% import-dependent market with over 500 exporting companies
-
GMP Certification Requirements
Building robust QA systems that satisfy CBPF, WHO GMP, or PIC/S certification requirements for ANVISA market access
-
Portuguese Documentation Standards
Preparing translated company credentials, product documentation, and labeling in Brazilian Portuguese with specific cannabinoid content declarations
What to Prepare Before Cannabis Fair Sao Paulo
Maximize your conference ROI by arriving prepared. Use this checklist to ensure you’re ready to make the most of every networking opportunity and business meeting.
Documents to Bring
- Company credentials translated to Portuguese
- GMP certifications (CBPF, WHO GMP, PIC/S) with Portuguese translations
- Product documentation suitable for ANVISA discussions
- Import license information (if applicable)
- COO (Certificate of Origin) documentation for products
- Business cards (Portuguese translations helpful)
Questions to Research
- Current status of PL 399/2015 cultivation bill
- Which Brazilian pharmaceutical companies hold ANVISA authorizations in your product category?
- What import timelines are typical for your product type?
- Which testing laboratories serve the Brazilian market?
- What compliance support services do Brazilian partners expect?
- What are the RDC 327/660 requirements for your products?
What to Compare
- Import Partners: Compare ANVISA authorization scope and capabilities
- Testing Laboratories: Evaluate lab capacity and turnaround times
- Distribution Networks: Assess geographic coverage (80%+ municipal coverage)
- Compliance Consultants: Compare regulatory service offerings and track records
- Logistics providers with cold-chain expertise
- Translation and localization service providers
Frequently Asked Questions
Common questions from cannabis professionals planning to attend Cannabis Fair Sao Paulo 2026.
Is Cannabis Fair Sao Paulo a B2B-only event?
Yes. Cannabis Fair Sao Paulo maintains a professional, business-to-business focus. The event targets industry stakeholders including manufacturers, distributors, pharmaceutical companies, service providers, and regulatory professionals rather than consumers.
What language is used at the event?
Portuguese is the primary language. While some exhibitors and attendees speak English, Portuguese fluency significantly enhances networking effectiveness. Consider bringing Portuguese-speaking team members or arranging professional interpretation.
Are international attendees welcome?
Absolutely. Brazil’s import-dependent model makes international partnerships essential. The event specifically facilitates connections between foreign cannabis companies and Brazilian pharmaceutical partners required for ANVISA registration. Over 500 international companies currently export to Brazil.
How do I purchase tickets?
Ticket information is available through the official Cannabis Fair website at cannabisfair.com.br. Registration typically opens several months before the event. Professional credentials may be required for entry.
What networking opportunities exist beyond the exhibition floor?
The 2026 edition introduces Sechat Talks, featuring expert presentations with live streaming. These sessions create additional touchpoints for industry discussions. Evening networking events are commonly organized by exhibitors and industry associations during the three-day event.
What is the 2026 cultivation bill status?
PL 399/2015, which passed a special committee in 2021, awaits plenary discussion. Brazilian legislators and researchers have identified 2026 as the “decisive year” for domestic cultivation authorization, with ANVISA Director Thiago Campos facing a March 2026 STJ deadline for cultivation regulation.
Software Solutions for Brazilian Cannabis Compliance
Cannabis operations expanding into the Brazilian market increasingly rely on seed-to-sale platforms capable of generating ANVISA-compliant documentation and managing import-dependent supply chain tracking. These systems help operators maintain audit-ready records across cultivation, processing, and distribution activities.
Attendees at Cannabis Fair Sao Paulo often evaluate technology solutions that can adapt to varying regulatory requirements while maintaining consistent operational workflows. As Brazil potentially transitions from import-dependency to domestic cultivation, flexible systems become essential for navigating this regulatory evolution.
Ready to Simplify Your Cannabis Compliance?
See how cannabis facilities serving Latin American markets use GrowerIQ to manage seed-to-sale traceability and regulatory reporting.
Request Demo
About GrowerIQ
GrowerIQ is a complete cannabis production management platform. Ours is the first platform to integrate your facility systems, including sensors, building controls, QMS, and ERP, into a single simplified interface.
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.